LY3484356

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY3484356, covering 2025-06-04 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer [Phase 1]